Gabapentin for anxiety
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin for Anxiety Disorders: Efficacy and Clinical Evidence
Overview of Gabapentin Use in Anxiety Treatment
Gabapentin, originally developed as an antiepileptic medication, is increasingly used off-label for anxiety disorders due to its favorable side effect profile and low risk of drug interactions. It is considered an alternative to traditional anxiolytics, especially for patients who cannot tolerate or do not respond to standard treatments like benzodiazepines or antidepressants Norton2001Greenblatt2018Ahmed2019.
Evidence from Clinical Trials and Case Studies
Several studies and reviews indicate that gabapentin can reduce anxiety symptoms in various populations. Randomized controlled trials have shown that gabapentin is more effective than placebo in reducing preoperative anxiety and anxiety symptoms in breast cancer survivors, with some evidence suggesting that lower doses may be particularly effective for patients with mild to moderate anxiety Lavigne2012Clarke2013Hong2021+1 MORE. In pediatric surgical patients, perioperative gabapentin administration also led to a significant reduction in postoperative anxiety .
Case reports and open-label studies further support gabapentin’s anxiolytic potential, including successful treatment of anxiety both with and without concurrent depression, and a clear dose-response relationship in patients with generalized anxiety disorder (GAD) Norton2001Markota2017. However, it is important to note that there are no large-scale randomized controlled trials specifically for GAD, and most evidence comes from case reports or studies in related anxiety conditions Markota2017Berlin2015.
Comparative Effectiveness and Safety
Systematic reviews and meta-analyses conclude that gabapentin and its related compound, pregabalin, show moderate evidence of efficacy in anxiety states, particularly for preoperative anxiety and social phobia Hong2021Berlin2015Ahmed2019. Pregabalin is approved for GAD in Europe, but gabapentin is not officially approved for any anxiety disorder in the US or Europe . Gabapentin is generally well-tolerated, with minimal risk of addiction or abuse, making it a suitable option for patients with a history of substance use or those reluctant to use controlled substances Lavigne2012Ahmed2019.
Limitations and Considerations
Despite promising results, the evidence base for gabapentin in anxiety disorders is limited by a lack of large, high-quality randomized controlled trials, especially for primary anxiety disorders like GAD Markota2017Berlin2015. Most studies focus on specific populations (e.g., cancer survivors, surgical patients) or use gabapentin as an adjunct rather than monotherapy Berlin2015Ahmed2019. Sedation is a common side effect, particularly at higher doses, and should be considered when prescribing gabapentin for anxiety .
Conclusion
Gabapentin appears to be a moderately effective and well-tolerated option for certain anxiety disorders, especially in patients who are unable or unwilling to use traditional anxiolytics. It is most commonly used off-label for preoperative anxiety, social phobia, and anxiety in specific populations such as cancer survivors. However, more robust clinical trials are needed to fully establish its efficacy and safety profile for generalized anxiety disorder and other primary anxiety conditions.
Sources and full results
Most relevant research papers on this topic